Crossmark

Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation

Crossref DOI link: https://doi.org/10.1016/j.htct.2020.09.148

Published Print: 2021-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ikoma-Colturato, Maura R.V. https://orcid.org/0000-0002-1473-9696
Beltrame, Miriam P. https://orcid.org/0000-0003-0148-998X
Furtado, Felipe M. https://orcid.org/0000-0001-8858-6656
Pimenta, Glicinia https://orcid.org/0000-0003-0461-6788
da Costa, Elaine Sobral https://orcid.org/0000-0002-5340-5816
Azambuja, Ana Paula https://orcid.org/0000-0001-9884-4735
Malvezzi, Mariester https://orcid.org/0000-0001-8820-2720
Yamamoto, Mihoko https://orcid.org/0000-0001-7881-1856
License Information

Text and Data Mining valid from 2021-07-01

Version of Record valid from 2020-11-14
More Information

This article is maintained by: Elsevier

Article Title: Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2020.09.148

Content Type: article

Copyright: © 2020 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.

Document is current

Any future updates will be listed below